Physician

Stephen J Gallo, M.D.

According to 2025 Medicare claims, Stephen Gallo, M.D. (NPI: 1013076546) practices urology in the Springfield, MA market, with the plurality of this provider's patient population coming from Hampden, MA. This provider's primary affiliated billing organization is PIONEER VALLEY UROLOGY, PC (NPI: 1750315982; TIN: 043249509) and primary practice location at 01107-1179. Gallo is affiliated with the Pioneer Valley Accountable Care, LLC (ACO ID: A5040), participating under the MSSP model.

Gallo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,775 traditional Medicare patients, billed 11,505 HCPCS/CPT codes, and received $507,913 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,311 prescription claims across 398 beneficiaries totaling $84,269 in drug costs, led by Gemtesa (Vibegron). DME data shows 68 claims. Open Payments data shows 8 records totaling $204. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $330,969 to $507,913. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $68,720 and ending at $84,269. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,294 to $432.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,058	6,428	$330,969
2016	1,118	6,222	$360,025
2017	1,060	5,152	$305,590
2018	1,204	4,653	$277,106
2019	1,278	6,585	$321,011
2020	1,188	5,287	$288,694
2021	1,373	8,653	$431,576
2022	1,711	12,140	$559,927
2023	1,679	8,575	$419,933
2024	1,775	11,505	$507,913

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	286	1,128	$68,720
2016	314	1,177	$72,759
2017	308	1,286	$89,342
2018	346	1,300	$71,050
2019	319	1,186	$114,878
2020	341	1,143	$62,629
2021	454	1,466	$76,094
2022	468	1,679	$89,357
2023	428	1,490	$104,783
2024	398	1,311	$84,269

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	28	318	$43,559
2016	N/R	283	$38,854
2017	N/R	257	$34,909
2018	N/R	179	$45,593
2019	11	221	$46,704
2020	N/R	124	$27,297
2021	N/R	88	$26,388
2022	N/R	92	$40,781
2023	N/R	59	$50,221
2024	N/R	68	$56,637

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	964	1,180	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	526	585	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,194	1,524	$12
51798	Ultrasound measurement of bladder capacity after voiding	599	660	$9
81003	Automated urinalysis test	830	971	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	31	2,310	$35,657
Myrbetriq	Mirabegron	32	1,440	$21,163
Finasteride	Finasteride	387	30,772	$6,768
Tamsulosin Hcl	Tamsulosin Hcl	392	29,372	$6,683
Oxybutynin Chloride Er	Oxybutynin Chloride	46	2,596	$1,961

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	29	$47,582
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	39	$9,055

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$204	Ferring Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephen J. Gallo, M.D.?

Tedicare shows public-source Medicare data for Stephen J. Gallo, M.D. (NPI 1013076546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen J. Gallo, M.D. have ACO affiliation data?

Stephen J. Gallo, M.D. is shown with ACO affiliation data for Pioneer Valley Accountable Care, LLC (MSSP, ACO ID A5040).

What billing organization is linked to Stephen J. Gallo, M.D.?

Stephen J. Gallo, M.D. is linked to PIONEER VALLEY UROLOGY, PC (billing NPI 1750315982) in the available physician profile data.

Does Stephen J. Gallo, M.D. have Open Payments data?

Stephen J. Gallo, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.